Status:
UNKNOWN
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy and safety of intravitreal injection of bevacizumab alone versus bevacizumab combined with triamcinolone for treatment of refractory diabetic macul...
Detailed Description
According to the early treatment diabetic retinopathy study (ETDRS), the treatment of choice for diabetic macular edema is laser therapy, which may be neither effective nor curative in some patients. ...
Eligibility Criteria
Inclusion
- Cases with clinically significant macular edema (CSME) with persistent retinal thickening after initial or supplemental macular photocoagulation
Exclusion
- Monocularity,
- History of vitrectomy,
- Glaucoma or ocular hypertension,
- Significant media opacity,
- Existence of traction on the macula
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00370422
Start Date
November 1 2005
End Date
September 1 2006
Last Update
March 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamid Ahmadieh, MD
Tehran, Tehran Province, Iran, 16666